Cited by 112Ovarian function and disordersAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Indices of low-grade inflammation in polycystic ovary syndrome

DIAMANTI‐KANDARAKIS, EVANTHIA, PATERAKIS, THOMAS, KANDARAKIS, HELEN A.·2006·Annals of the New York Academy of Sciences

DOI 10.1196/annals.1365.015

Open this paper in CoChat — free account

Abstract

Polycystic ovary syndrome (PCOS) is probably the most common endocrinopathy of reproductive age. PCOS represents a disorder that not only enhances the risk for type 2 diabetes (T2D) but is also associated with an increased number of cardiovascular risk factors known to facilitate atherogenesis. On the other hand, inflammation is thought to play an important role in the progression and development of complications of atherosclerosis. Evidence of low-grade chronic inflammation in PCOS is indicated by the presence of elevated C-reactive protein (CRP) levels, inflammatory cytokines (i.e., IL-6 and IL-18), and increased leucocyte count. CRP, a nonspecific marker of inflammation, has been proven to be one of the strongest predictors of the risk of cardiovascular events in patients with or without cardiovascular disease. The levels of the adhesion molecules (AM), sIVAM-1, sVCAM-1, and sE-selectin in serum reflect low-grade chronic inflammation of the endothelium and independently predict coronary heart disease (CHD) and T2D. In a recent study in a large number of PCOS women we demonstrated elevated levels of sIVAM-1 and sE-selectin and we further substantiated the existence of a low-grade chronic inflammatory process in PCOS. However, it remains to be assessed with long-term studies whether the early presence of markers of chronic inflammation in young women with this syndrome has clinical significance.

Integrity signals

Registry

Crossref · 10.1196/annals.1365.015

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692

Show all 78 references

Research works printed but not linked: 4

10.1210/jc.81.1.302 · DOI · Paper page
10.1161/01.ATV.15.7.821 · DOI
10.1056/NEJMoa040967 · DOI
10.1210/jc.87.3.1134 · DOI

Sorted by citations

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Self-citation
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 538
Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, but Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1290 · Cited by 369
Inter‐related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS
Shorakae, S., Ranasinha, S., Abell, S., Lambert, G., Lambert, E., de Courten, B., & Teede, H. (2018) · Clinical Endocrinology · doi:10.1111/cen.13808 · Cited by 176
Involvement of androgens in ovarian health and disease
Lebbe, M., & Woodruff, T. K. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat065 · Cited by 165
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS Patients
Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154
Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients
Sun, L., Hu, W., Liu, Q., Hao, Q., Sun, B. H., Zhang, Q., Mao, S., Qiao, J., & Yan, X. (2012) · Journal of Proteome Research · doi:10.1021/pr3000317 · Cited by 155
Disturbed stress responses in women with polycystic ovary syndrome
Benson, S., Arck, P., Tan, S., Hahn, S., Mann, K., Rifaie, N., Janssen, O. E., Schedlowski, M., & Elsenbruch, S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.001 · Cited by 142
Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
Tan, B. K., Adya, R., Syed, F., Chen, J., Lehnert, H., & Randeva, H. S. (2010) · Diabetes · doi:10.2337/db10-0124 · Cited by 138
Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome
Adams, J. E., Liu, Z., Ren, Y. A., Wun, W.-S. A., Zhou, W. J., Kenigsberg, S., Librach, C. L., Valdés, C. T., Gibbons, W. E., & Richards, J. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4275 · Cited by 133
Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells
Tan, B. K., Adya, R., Chen, J., Lehnert, H., Cassia, L. J. S., & Randeva, H. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1803 · Cited by 129
Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128
The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Akbari, M., Ostadmohammadi, V., Lankarani, K. B., Tabrizi, R., Kolahdooz, F., Heydari, S. T., Kavari, S. H., Mirhosseini, N. Z., Mafi, A., Dastorani, M., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/s-0044-101355 · Cited by 124
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 120
Self-citation
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
Lorenzo, M. D., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 149
Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies
Behboudi‐Gandevani, S., Tehrani, F. R., Dovom, M. R., Farahmand, M., Khomami, M. B., Noroozzadeh, M., Kabir, A., & Azizi, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1117069 · Cited by 113
The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis
Khalafi, M., & Symonds, M. E. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13754 · Cited by 116
Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis
Tarantino, G., Valentino, R., Somma, C. D., D’Esposito, V., Passaretti, F., Pizza, G., Brancato, V., Orio, F., Formisano, P., Colao, A., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04500.x · Cited by 105
A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes
Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98
Polycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 101
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener‐Victorin, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2279 · Cited by 93
Role of Androgen Excess on Metabolic Aberrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome
Christakou, C. D., & Diamanti‐Kandarakis, E. (2008) · Women s Health · doi:10.2217/17455057.4.6.583 · Cited by 91
Self-citation
Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial
Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89
NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndrome‡
Wang, Y., Yang, Q., Wang, H., Zhu, J., Cong, L., Li, H., & Sun, Y. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab078 · Cited by 78
Metformin Increases the Novel Adipokine Cartonectin/CTRP3 in Women With Polycystic Ovary Syndrome
Tan, B. K., Chen, J., Hu, J., Amar, O., Mattu, H. S., Adya, R., Patel, V. C., Ramanjaneya, M., Lehnert, H., & Randeva, H. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2227 · Cited by 72
Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review
Xu, X., Du, C., Zheng, Q., Peng, L., & Sun, Y. (2014) · BMC Women s Health · doi:10.1186/1472-6874-14-93 · Cited by 67
Metabolic syndrome and polycystic ovary syndrome... and vice versa
Kandaraki, E., Christakou, C. D., & Diamanti‐Kandarakis, E. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200014 · Cited by 67
Self-citation
Adipose expression of adipocytokines in women with polycystic ovary syndrome
Svendsen, P. F., Christiansen, M., Hedley, P. L., Nilas, L., Pedersen, S. B., & Madsbad, S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.056 · Cited by 67
Elevated Levels of Follicular Fatty Acids Induce Ovarian Inflammation via ERK1/2 and Inflammasome Activation in PCOS
Lai, Y.-C., Ye, Z., Mu, L., Zhang, Y., Long, X., Zhang, C., Li, R., Zhao, Y., & Qiao, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac281 · Cited by 68
Food and Western Disease Health and Nutrition from an Evolutionary Perspective
Lindeberg, S. (2009) · Cited by 64
Current and experimental drug therapy for the treatment of polycystic ovarian syndrome
Corte, L. D., Foreste, V., Barra, F., Gustavino, C., Alessandri, F., Centurioni, M. G., Ferrero, S., Bifulco, G., & Giampaolino, P. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1781815 · Cited by 65
Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents with Polycystic Ovary Syndrome
Pawelczak, M., Rosenthal, J. A., Milla, S. S., Liu, Y., & Shah, B. C. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.01.104 · Cited by 52
No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls
Lindholm, A., Blomquist, C. H., Bixo, M., Dahlbom, I., Hansson, T., Poromaa, I. S., & Burén, J. (2011) · Human Reproduction · doi:10.1093/humrep/der096 · Cited by 51
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls
Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51
Self-citation
The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction
Pepene, C. E., Ilie, I. R. P., Marian, I., & Duncea, I. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0720 · Cited by 49
The role of stress in PCOS
Papalou, O., & Diamanti-Kandarakis, E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1266250 · Cited by 47
Self-citation
Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping
Caserta, D., Adducchio, G., Picchia, S., Ralli, E., Matteucci, E., & Moscarini, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.887673 · Cited by 43
C1QTNF6 participates in the pathogenesis of PCOS by affecting the inflammatory response of granulosa cells
Yan, S., Ding, J., Zhang, Y., Wang, J., Zhang, S., Yin, T., & Yang, J. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab094 · Cited by 43
Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism
Lin, Y.-S., Tsai, S., Lin, M., Yang, C., Huang, M., & Wu, M. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01059.x · Cited by 42
White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia
Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1563 · Cited by 43
Self-citation
Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome
Androulakis, I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti-Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 46
Self-citation
Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome
Ribeiro, V. B., Kogure, G. S., Lopes, I. P., Silva, R. C., Pedroso, D. C. C., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000157 · Cited by 39
Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations
Ferreira, S. R., & Motta, A. B. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205144119 · Cited by 36
Obesity and inflammatory biomarkers in women with polycystic ovary syndrome
Shen, S.-H., Shen, S.-Y., Liou, T., Hsu, M.-I., Chang, Y. I., Cheng, C.-Y., Hsu, C.-S., & Tzeng, C. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.022 · Cited by 35
Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway
Tan, B. K., Chen, J., Adya, R., Ramanjaneya, M., Patel, V. C., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0277 · Cited by 33
Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome
Eken, M. K., Ersoy, G. Ş., Abide, Ç. Y., Şanverdi, İ., Devranoğlu, B., Kutlu, T., & Çevik, Ö. D. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1581754 · Cited by 32
Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS)
Giallauria, F., Palomba, S., de Sio, I., Maresca, L., Vuolo, L., Savastano, S., Lombardi, G., Colao, A., Vigorito, C., & Orio, F. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03336.x · Cited by 33
Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
Jabarpour, M., Amidi, F., Aleyasin, A., Nashtaei, M. S., & Saedi-Marghmaleki, M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18464 · Cited by 31
Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
Kim, J., Choi, Y. M., Hong, M. A., Kim, M.-J., Chae, S. J., Kim, S. M., Hwang, K. R., Yoon, S. H., Ku, S., Suh, C. S., et al. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.2.253 · Cited by 26
Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome
Tosi, F., Sarra, D. D., Bonin, C., Zambotti, F., Dall'Alda, M., Fiers, T., Kaufman, J., Donati, M., Franchi, M. P., Zanolin, M. E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0761 · Cited by 26
New insights into the ovulatory process in the human ovary
Jo, M., Brännström, M., Akins, J. W., & Curry, T. E. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae027 · Cited by 25
The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
Rojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 26
Successful Treatment of Hidradenitis Suppurativa with Infliximab in a Patient Who Failed to Respond to Etanercept
Poulin, Y. P. (2009) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2008.08034 · Cited by 25
Interleukin 1 beta (IL-1β) promoter C [−511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome
Mu, Y., Liu, J., Wang, B., Wen, Q., Wang, J., Yan, J., Zhou, S., Ma, X., & Cao, Y. (2009) · Endocrine · doi:10.1007/s12020-009-9268-x · Cited by 24
High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome
Kim, J. W., Han, J. E., Kim, Y. S., Won, H. J., Yoon, T. K., & Lee, W. S. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.613967 · Cited by 23
Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research
Yang, K., Zeng, L., Bao, T., Long, Z., & Jin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54408-3 · Cited by 23
The Possible Practical Implication of High CRP Levels in PCOS
Blumenfeld, Z. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119861936 · Cited by 23
ORIGINAL ARTICLE: Uterine Leiomyoma is Associated with a Polymorphism in the Interleukin 1‐β Gene
Pietrowski, D., Thewes, R., Sator, M. O., Denschlag, D., Keck, C., & Tempfer, C. M. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00718.x · Cited by 22
Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy
Diamanti‐Kandarakis, E., Economou, F., Livadas, S., Tantalaki, E., Piperi, C., Papavassiliou, A. G., & Panidis, D. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000201791 · Cited by 22
Self-citation
Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome
Zoppini, G., Bonora, E., Moghetti, P., & Targher, G. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1384512 · Cited by 21
Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome
Jones, M. R., Chua, A. K., Chen, Y. I., Li, X., Krauss, R. M., Rotter, J. I., Legro, R. S., Azziz, R., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020120 · Cited by 20
Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome
Lindholm, Å., Bixo, M., Eliasson, M., Hudecova, M., Arnadottir, R., Holte, J., & Poromaa, I. S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487592 · Cited by 19
Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention
Moran, L., Meyer, C., Hutchison, S. K., Zoungas, S., & Teede, H. J. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345790 · Cited by 19
The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: Role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis
Tan, B. K., Adya, R., Shan, X., Aghilla, M., Lehnert, H., Keay, S. D., & Randeva, H. S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.069 · Cited by 18
Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk
Dasanu, C. A., Clark, B. A., Ichim, T. E., & Alexandrescu, D. T. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e31820c0172 · Cited by 17
Role and interactions of annexin A 1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation
Hughes, E. L., Cover, P. O., Buckingham, J. C., & Gavins, F. N. E. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02146.x · Cited by 17
Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors
Barcellos, C. R. G., Rocha, M. P., Hayashida, S. A. Y., Dantas, W. S., Yance, V. D. R. V., & Marcondes, J. A. M. (2015) · HORMONES · doi:10.14310/horm.2002.1584 · Cited by 17
Increased circulating soluble P-selectin in polycystic ovary syndrome
Yıldız, B. O., Bozdağ, G., Harmancı, A., Otegen, U., Boynukalin, K., Vural, Z., Kirazlı, Ş., Haznedaroğlu, İ. C., & Yaralı́, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.121 · Cited by 16
Soluble adhesion molecules levels in patients with Cushing’s syndrome before and after cure
Ermetici, F., Malavazos, A. E., Corbetta, S., Eller-Vainicher, C., Cannavò, S., Corsi, M. M., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346381 · Cited by 16
Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
Mansour, A., Hosseini, S., Larijani, B., & Mohajeri-Tehrani, M. R. (2016) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2016-422 · Cited by 15
Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome
Kim, J. W., Lee, M. H., Park, J. E., Yoon, T. K., Lee, W. S., & Shim, S. H. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.12.008 · Cited by 15
Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome
Hesampour, F., Jahromi, B. N., Tahmasebi, F., & Gharesi‐Fard, B. (2019) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v18i1.634 · Cited by 14
Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?
Rey-Roldán, E. B., Lana, M. B. P., Galluzzo, L., Blanco, G., Onetto, C., Straminsky, V., & Nolting, M. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.730581 · Cited by 14
Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome
Li, L., Ryoo, J. E., Lee, K.-J., Choi, B. C., & Baek, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123045 · Cited by 13
Independent predictors of cardiovascular risk in polycystic ovarian syndrome
Türkçüoğlu, İ., Kafkaslı, A., Meydanlı, M. M., Özyalın, F., & Taşkapan, Ç. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.551566 · Cited by 12
IL ‐1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome
Luotola, K., Piltonen, T., Puurunen, J., & Tapanainen, J. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13077 · Cited by 12
Impact of Androgen and Dietary Advanced Glycation End Products on Female Rat Liver
Palioura, E., Palimeri, S., Piperi, C., Sakellariou, S., Kandaraki, E., Sergentanis, T. Ν., Levidou, G., Agrogiannis, G. D., Papalois, A. E., Korkolopoulou, P. A., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430400 · Cited by 12
Self-citation
Effects of kefir consumption on gut microbiota and health outcomes in women with polycystic ovary syndrome
Dazıroğlu, M. E. Ç., Tek, N. A., Akdulum, M. F. C., Yılmaz, C., & Yalınay, A. M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4212 · Cited by 12
Disrupting Interleukin 12 Improves Microvascular Endothelial Function in Type 2 Diabetes Through ER Stress CHOP and Oxidative Stress Mechanisms
Radwan, E., Belmadani, S., & Matrougui, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369488 · Cited by 11
The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
Ilie, I. R. P., Pepene, C. E., Marian, I., Mocan, T., Hazi, G. M., Dragotoiu, G., Ilie, R., MOCAN, L. C., & Duncea, I. (2010) · Open Medicine · doi:10.2478/s11536-010-0054-1 · Cited by 11
RETRACTED ARTICLE: Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease
Seyam, E., Hasan, M., Khalifa, E. M., Ramadan, A., & Hefzy, E. M. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1320383 · Cited by 11
Retracted
Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00347-8 · Cited by 11
Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and hyperandrogenemia
Ilie, I. R. P., Pepene, C. E., Duncea, I., & Ilie, R. (2008) · Open Medicine · doi:10.2478/s11536-008-0044-8 · Cited by 10
Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome
Zheng, C.-Y., Yu, Y., & Bai, X. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.02.013 · Cited by 9
Lack of association between interleukin-1a gene (IL-1a) C (-889) T variant and polycystic ovary syndrome in chinese women
Wang, B., Zhou, S., Wang, J., Liu, J., Ni, F., Liu, C., Yan, J., Mu, Y., Cao, Y., & Ma, X. (2009) · Endocrine · doi:10.1007/s12020-009-9152-8 · Cited by 9
Effect of colchicine on polycystic ovary syndrome: an experimental study
Gözükara, İ., Pınar, N., Özcan, O., Özgür, T., Dokuyucu, R., Kurt, R. K., Kucur, S. K., & Aksoy, A. N. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3933-5 · Cited by 9
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes
Moro, F., Tropea, A., Scarinci, E., Federico, A., SIMONE, C. D., Caldarola, G., Leoncini, E., Boccia, S., Lanzone, A., & Apa, R. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.002 · Cited by 9
3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples
Zeng, L., Lu, R., Xie, L., Jiang, X., Chen, Y., Huang, C., Chen, Y., Liu, G., & Sun, W.-X. (2021) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207321666210602170054 · Cited by 9
The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
Kassi, E. N., & Diamanti‐Kandarakis, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345663 · Cited by 8
Self-citation
Common Inflammatory Markers in Polycystic Ovary Syndrome (PCOS): A BMI (Body Mass Index)-Matched Case–Control Study
Bhattacharya, S. M., & Basu, A. (2018) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-018-1143-3 · Cited by 8
The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer
Kumar, S., Prajapati, K. S., & Gupta, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810577 · Cited by 8
Circulating SCUBE1 levels in women with polycystic ovary syndrome
Erol, O., Elli̇dağ, H. Y., Özel, M. K., Uysal, A., Eren, E., & Yılmaz, N. (2018) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.25826 · Cited by 6
Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome
Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., ERALDEMİR, F. C., & Şahin, D. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01392-9 · Cited by 5
Low-Calorie Sweeteners and Reproductive Health: Evidence and Debates
Atalay, E. Ç., Demirhan, B. E., & Celep, G. S. (2024) · Current Nutrition & Food Science · doi:10.2174/0115734013315621240802055207 · Cited by 8
Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate resistant polycystic ovary disease
Seyam, E., Hasan, M., Khalifa, E. M., Ramadan, A., & Hefzy, E. M. (2017) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2017.01.008 · Cited by 4
Cardiopulmonary functional capacity and the role of exercise in improving maximal oxygen consumption in women with PCOS.
Lenarcik, A., & Bidzińska−Speichert, B. (2010) · PubMed · Cited by 4

Authors: DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A.
Affiliations: National and Kapodistrian University of Athens (GR)
ORCID: DIAMANTI‐KANDARAKIS, EVANTHIA
Venue: Annals of the New York Academy of Sciences
Publisher: Wiley
Published: 2006-12
Volume: 1092
Issue: 1
Pages: 175-186
ISSN: 0077-8923 (ISSN-L)
1749-6632
DOI: 10.1196/annals.1365.015
OpenAlex: W2031937096
Cited by: 112
References: 78
Citations by year: 2026: 3 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 10 · 2013: 5 · 2012: 8
FWCI: 1.02
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 61 d)
Locations: Annals of the New York Academy of Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, low-grade inflammation, C-reactive protein, inflammatory cytokines, interleukin-6, IL-18, sICAM-1, sVCAM-1, soluble E-selectin, adhesion molecules, endothelial inflammation, cardiovascular risk, type 2 diabetes, coronary artery disease
MeSH terms: C-Reactive Protein, Female, Humans, Inflammation, Leukocyte Count, Polycystic Ovary Syndrome, Severity of Illness Index, Biomarkers, Cell Adhesion Molecules, Cytokines, E-Selectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Indices of low-grade inflammation in polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks